We caught up with Dr. Richard Whitlock to learn more about the BoxX-NoAF clinical trial and its goal: studying whether performing surgical ablation and LAAE during cardiac surgery can help prevent new-onset, post-op Afib in patients with risk factors but no prior history of Afib.
The study is actively enrolling. Learn more: <a href="https://okt.to/Fnmeh0" target="_blank">https://okt.to/Fnmeh0</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a>
